PAMELA WIATROWSKI: Open Payments
NPI 1558994608 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 64 payments from 18 companies in 2025. Trend: 2023 $1,500 · 2024 $1,251 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $143 |
| Novo Nordisk Inc | 8 | $140 |
| Merck Sharp & Dohme LLC | 7 | $118 |
| BridgeBio Pharma, Inc. | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Boston Scientific Corporation | 3 | $52 |
| SCPHARMACEUTICALS INC. | 3 | $51 |
Products named: VERQUVO, Wegovy, Attruby, ELIQUIS, LEQVIO, JARDIANCE, FARXIGA, CAMZYOS.
Industry payments across NY — which companies pay providers there.
